Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,528,797
+$4,506,880 QoQ
Shares Held
430,463
+88.5% QoQ
Ownership
0.968%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $1,135,897,995 across 44 Drug Manufacturers - Specialty & Generic names. BIOA ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,649,955 | $195,041,180 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,315,973 | $171,402,644 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,247,447 | $164,338,667 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,595,535 | $140,071,906 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
153,372 | $90,946,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,893,845 | $57,042,611 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,279,731 | $45,964,310 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
592,013 | $45,525,799 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,528,797 | 430,463 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,021,917 | 228,414 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,802,525 | 306,552 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $148,981 | 36,073 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $86,647 | 14,965 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,453,257 | 166,022 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||